ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2761 - 2775 of 5662 products
Beijing's AK Medical Buys JRI Orthopedics of the UK for $24 Million
$5.00
Available
Beigene Initiated Global Phase II Clinical Trial for PD-1 Antibody
$5.00
Available
Biocytogen Closes $65 Million Round for Animal Model CRO Services
$5.00
Available
DXY Completes $100 Million Series D Round for China Doctor Academic Portal
$5.00
Available
Bliss Biopharma of Hangzhou Licenses Cancer ADC from Morphotek
$5.00
Available
Panacea Ventures Files to Raise $150 Million for China Healthcare
$5.00
Available
New World Development Invests in New Century Healthcare; Plans More China Clinics/Hospitals
$5.00
Available
Frontage Labs, a US-China CRO, Acquires Concord Biosciences
$5.00
Available
US-China Trade War May Affect Life Science Products
$5.00
Available
Denovo Starts US-China Phase III Study of Leukemia Treatment
$5.00
Available
Concord Medical Announces $238 Million Investment from CCIC
$5.00
Available
Terns Acquires Three Lilly Candidates; Raises $30 Million from Lilly Asia Ventures
$5.00
Available
China Moves to Encourage Higher Quality China-made Generic Drugs
$5.00
Available
Fosun Pharma Stays Committed to Expanding through R&D and M&A
$5.00
Available
CMAB Biopharma of Suzhou Announces $34 Million Series B
$5.00
Available